Article
Uncoupling of CSF biomarkers and clinical status in patients with a novel mutation of ATP13a2
2025-09-05
Abstract excerpt
<h4>Summary</h4> Cerebrospinal fluid (CSF) biomarkers are generally assumed to reflect the severity and progression of neurodegenerative disease. We report three siblings carrying a novel heterozygous ATP13A2 variant (p.Pro629Ser) who challenge this paradigm. Despite only slowly progressive cognitive decline, axonal neuropathy, and leukodystrophy on MRI, all established CSF markers of neuronal destruction were pr...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 67a2c172-cf04-536d-b94b-79e3c20cf328
- DOI
- 10.1101/2025.09.02.25334661
